Doescher: I just want to make sure I get that. Haislmaier: The drug, the list price goes up. Doescher: Yes. The price for my insulin goes up. Haislmaier: And you may be paying more as the patient ...
which are negotiated with drug manufacturers and are tied to a drug’s list price. Insulin products with higher list prices ...
Semglee has been approved for over a year as a regular biosimilar to Lantus (insulin glargine), meaning that it could be used in place of Sanofi's drug ... typically have list prices 15% to ...